Kalaris Therapeutics, Inc.
KLRS
$4.75
$0.020.42%
NASDAQ
| 06/30/2025 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Net Income | -11.32% | -65.84% | |||
| Total Depreciation and Amortization | -- | -- | |||
| Total Amortization of Deferred Charges | -100.00% | 69.10% | |||
| Total Other Non-Cash Items | 165.02% | 201.78% | |||
| Change in Net Operating Assets | -175.87% | 91.71% | |||
| Cash from Operations | -68.51% | 12.17% | |||
| Capital Expenditure | -- | -- | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -- | -- | |||
| Cash from Investing | -- | -- | |||
| Total Debt Issued | -100.00% | 0.14% | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | -- | -- | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -100.00% | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -100.00% | -240.00% | |||
| Cash from Financing | -100.00% | -24.26% | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -112.56% | -50.83% | |||